Revvity, Inc. SEC filings RVTY
Revvity, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Aug 2, 2012. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 29, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jul 5, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, other events). The company's fiscal year ends on December 29.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 16, 2026 | — |
| DEF 14A | Proxy statement | Mar 16, 2026 | Apr 28, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 6, 2026 | Apr 28, 2026 |
| DEFA14A | Additional proxy material | Mar 12, 2025 | — |
| DEF 14A | Proxy statement | Mar 12, 2025 | Apr 22, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 26, 2025 | Apr 22, 2025 |
| DEFA14A | Additional proxy material | Mar 13, 2024 | — |
| DEF 14A | Proxy statement | Mar 13, 2024 | Apr 23, 2024 |
| DEFA14A | Additional proxy material | Mar 8, 2023 | — |
| DEF 14A | Proxy statement | Mar 8, 2023 | — |
| DEFA14A | Additional proxy material | Mar 9, 2022 | — |
| DEF 14A | Proxy statement | Mar 9, 2022 | Apr 26, 2022 |
| DEFA14A | Additional proxy material | Mar 10, 2021 | — |
| DEF 14A | Proxy statement | Mar 10, 2021 | Apr 27, 2021 |
| DEFA14A | Additional proxy material | Jan 11, 2021 | — |
| DEFA14A | Additional proxy material | Jan 7, 2021 | — |
| DEFA14A | Additional proxy material | Apr 14, 2020 | — |
| DEFA14A | Additional proxy material | Mar 11, 2020 | — |
| DEF 14A | Proxy statement | Mar 11, 2020 | Apr 28, 2020 |
| DEFA14A | Additional proxy material | Mar 13, 2019 | — |
| DEF 14A | Proxy statement | Mar 13, 2019 | Apr 23, 2019 |
| DEFA14A | Additional proxy material | Mar 14, 2018 | — |
| DEF 14A | Proxy statement | Mar 14, 2018 | Apr 24, 2018 |
| DEFA14A | Additional proxy material | Mar 8, 2017 | — |
| DEF 14A | Proxy statement | Mar 8, 2017 | Apr 25, 2017 |
| DEFA14A | Additional proxy material | Mar 9, 2016 | — |
| DEF 14A | Proxy statement | Mar 9, 2016 | Apr 26, 2016 |
| DEFA14A | Additional proxy material | Mar 11, 2015 | — |
| DEF 14A | Proxy statement | Mar 11, 2015 | Apr 28, 2015 |
| DEFA14A | Additional proxy material | Mar 12, 2014 | — |
| DEF 14A | Proxy statement | Mar 12, 2014 | Apr 22, 2014 |
| DEFA14A | Additional proxy material | Mar 13, 2013 | — |
| DEF 14A | Proxy statement | Mar 13, 2013 | Apr 23, 2013 |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- RVTY (NYSE)
- Fiscal year ends
- December 29
- Incorporated in
- MA
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 31791
- Former names
- PERKINELMER INC (until Apr 14, 2023); EG&G INC (until Jul 26, 1999)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Source: SEC EDGAR filings. This is company-reported data, not investment advice.